Weimin Ding
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
-
- RNA modifications and cancer 2
-
- Tracheal and airway disorders 2
- Ferroptosis and cancer prognosis 2
- Co-authors
- Jian Zhang (6 shared papers)Peng Luo (6 shared papers)Anqi Lin (4 shared papers)Guo‐Chang Fan (3 shared papers)Tianqing Peng (3 shared papers)Ting Cao (3 shared papers)Rui Ni (2 shared papers)Xiaoyun Ji (2 shared papers)
- Journals
- The Journal of Cell Biology (1 paper)Frontiers in Veterinary Science (1 paper)Cancer Biomarkers (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Weimin Ding
24 papers receiving 297 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 63
- Oncology 100
- Parasitology 18
- Molecular Biology 171
- Immunology 49
Countries citing papers authored by Weimin Ding
This map shows the geographic impact of Weimin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Ding more than expected).
Fields of papers citing papers by Weimin Ding
This network shows the impact of papers produced by Weimin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Ding. The network helps show where Weimin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Weimin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 54 | |
| 2 | 2022 | 31 | |
| 3 | 2020 | 31 | |
| 4 | 2021 | 27 | |
| 5 | 2015 | 25 | |
| 6 | 2023 | 22 | |
| 7 | 2004 | 18 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 9 | |
| 11 | 2004 | 9 | |
| 12 | 2022 | 8 | |
| 13 | CARD11 alteration as a candidate biomarker of skin cutaneous melanoma treated with immune checkpoint blockade. | 2021 | 8 |
| 14 | 2022 | 7 | |
| 15 | 2018 | 7 | |
| 16 | 2021 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2010 | 3 | |
| 20 | [Transferrin receptor expression of human mesenchymal stem cells and in vitro tracking by autoradiography after transplantation in spinal cord]. | 2004 | 3 |
About Weimin Ding
Weimin Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 25 papers that have together received 307 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Airway Management and Intubation Techniques (2 papers), Tracheal and airway disorders (2 papers), RNA modifications and cancer (2 papers), Boron Compounds in Chemistry (2 papers), Ferroptosis and cancer prognosis (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Cancer Research (63 citations), Oncology (100 citations), Parasitology (18 citations), Molecular Biology (171 citations) and Immunology (49 citations). Weimin Ding has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jian Zhang, Peng Luo, Anqi Lin, Guo‐Chang Fan, Tianqing Peng, Ting Cao, Rui Ni, Xiaoyun Ji, Hui Meng and Zhu‐Xu Zhang. Their work appears in journals such as The Journal of Cell Biology, Frontiers in Veterinary Science, Cancer Biomarkers, Frontiers in Cell and Developmental Biology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.